- Investing Ideas
- South Korean Pharmaceuticals & Biotech Upcoming Dividends
South Korean Pharmaceuticals & Biotech Upcoming Dividends
Results
9
Companies which have announced upcoming dividend payments.
9 companies
JW Holdings
Market Cap: ₩290.9b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,170.00
7D
-2.3%
1Y
36.9%
JW Lifescience
Market Cap: ₩199.1b
Provides national infusion solutions in South Korea and internationally.
A234080
₩12,790.00
7D
-1.1%
1Y
13.7%
Sam-A Pharm
Market Cap: ₩99.5b
Operates as a pharmaceutical company in South Korea.
A009300
₩16,190.00
7D
-0.4%
1Y
-2.2%
JW Pharmaceutical
Market Cap: ₩706.7b
Manufactures and sells medicines and medical supplies in Japan and internationally.
A001060
₩30,300.00
7D
-3.2%
1Y
38.4%
Seoulin BioscienceLtd
Market Cap: ₩57.3b
A bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea.
A038070
₩6,490.00
7D
0.6%
1Y
-9.9%
Boryung
Market Cap: ₩834.7b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩9,840.00
7D
-2.1%
1Y
15.1%
Huons
Market Cap: ₩308.8b
Provides medical solutions for human health in Korea and internationally.
A243070
₩26,700.00
7D
-0.4%
1Y
7.4%
Huons Global
Market Cap: ₩720.0b
Manufactures and sells pharmaceutical products for human health in South Korea and internationally.
A084110
₩58,200.00
7D
8.4%
1Y
14.8%
Chong Kun Dang Holdings
Market Cap: ₩240.4b
Manufactures and distributes pharmaceutical products in South Korea and internationally.
A001630
₩50,900.00
7D
4.4%
1Y
11.3%